Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-02-09
1986-06-17
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514277, 546269, 546285, C07D40704
Patent
active
045956898
ABSTRACT:
A method of treating inflammation which comprises topically administering to the affected area a compound of the formula ##STR1## or a pharmaceutically acceptable addition salt thereof, is described.
REFERENCES:
patent: 3479356 (1969-11-01), Fouche et al.
Fouche, C.A. 77811t, vol. 70, 1969.
Societe et al., C.A. 81186f, vol. 71, 1969.
Fouche, C.A. 70656u, vol. 80, 1974 and C.A. 66848a, vol. 72, 1970.
Societe, C.A. 5738e, vol. 75, 1971.
Boris Alfred
Guthrie Robert W.
Kierstead Richard W.
Boxer Matthew
Fan Jane T.
Hoffmann-La-Roche Inc.
Leon Bernard S.
Saxe Jon S.
LandOfFree
4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2273419